Cramer Rosenthal McGlynn’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$363K | – | 103 |
|
|
2024
Q1 | $363K | Hold |
1,000
| – | – | 0.02% | 103 |
|
|
2023
Q4 | $299K | Hold |
1,000
| – | – | 0.02% | 103 |
|
|
2023
Q3 | $286K | Hold |
1,000
| – | – | 0.02% | 101 |
|
|
2023
Q2 | $281K | Hold |
1,000
| – | – | 0.01% | 101 |
|
|
2023
Q1 | $256K | Hold |
1,000
| – | – | 0.01% | 102 |
|
|
2022
Q4 | $331K | Hold |
1,000
| – | – | 0.01% | 101 |
|
|
2022
Q3 | $277K | Hold |
1,000
| – | – | 0.01% | 102 |
|
|
2022
Q2 | $264K | Hold |
1,000
| – | – | 0.01% | 99 |
|
|
2022
Q1 | $240K | Hold |
1,000
| – | – | 0.01% | 95 |
|
|
2021
Q4 | $230K | Hold |
1,000
| – | – | 0.01% | 92 |
|
|
2021
Q3 | $200K | Buy |
+1,000
| New | +$217K | 0.01% | 96 |
|
|
2020
Q4 | – | Sell |
-200
| Closed | -$34K | – | 97 |
|
|
2020
Q3 | $34K | Hold |
200
| – | – | ﹤0.01% | 89 |
|
|
2020
Q2 | $38K | Sell |
200
-800
| -80% | -$152K | ﹤0.01% | 96 |
|
|
2020
Q1 | $177K | Hold |
1,000
| – | – | 0.01% | 97 |
|
|
2019
Q4 | $204K | Hold |
1,000
| – | – | 0.01% | 101 |
|
|
2019
Q3 | $152K | Hold |
1,000
| – | – | ﹤0.01% | 117 |
|
|
2019
Q2 | $158K | Hold |
1,000
| – | – | ﹤0.01% | 111 |
|
|
2019
Q1 | $161K | Hold |
1,000
| – | – | ﹤0.01% | 119 |
|
|
2018
Q4 | $190K | Hold |
1,000
| – | – | ﹤0.01% | 130 |
|
|
2018
Q3 | $208K | Hold |
1,000
| – | – | ﹤0.01% | 131 |
|
|
2018
Q2 | $170K | Hold |
1,000
| – | – | ﹤0.01% | 133 |
|
|
2018
Q1 | $168K | Hold |
1,000
| – | – | ﹤0.01% | 140 |
|
|
2017
Q4 | $203K | Hold |
1,000
| – | – | ﹤0.01% | 145 |
|
|
2017
Q3 | $187K | Hold |
1,000
| – | – | ﹤0.01% | 153 |
|
|
2017
Q2 | $167K | Hold |
1,000
| – | – | ﹤0.01% | 161 |
|
|
2017
Q1 | $146K | Hold |
1,000
| – | – | ﹤0.01% | 197 |
|
|
2016
Q4 | $133K | Hold |
1,000
| – | – | ﹤0.01% | 199 |
|
|
2016
Q3 | $130K | Hold |
1,000
| – | – | ﹤0.01% | 195 |
|
|
2016
Q2 | $128K | Hold |
1,000
| – | – | ﹤0.01% | 200 |
|
|
2016
Q1 | $137K | Hold |
1,000
| – | – | ﹤0.01% | 198 |
|
|
2015
Q4 | $146K | Hold |
1,000
| – | – | ﹤0.01% | 209 |
|
|
2015
Q3 | $135K | Hold |
1,000
| – | – | ﹤0.01% | 220 |
|
|
2015
Q2 | $162K | Hold |
1,000
| – | – | ﹤0.01% | 211 |
|
|
2015
Q1 | $129K | Hold |
1,000
| – | – | ﹤0.01% | 211 |
|
|
2014
Q4 | $103K | Hold |
1,000
| – | – | ﹤0.01% | 209 |
|
|
2014
Q3 | $91K | Hold |
1,000
| – | – | ﹤0.01% | 218 |
|
|
2014
Q2 | $92K | Sell |
1,000
-540,891
| -100% | -$46.4M | ﹤0.01% | 247 |
|
|
2014
Q1 | $45.4M | Sell |
541,891
-426,418
| -44% | -$35.1M | 0.35% | 109 |
|
|
2013
Q4 | $84.7M | Sell |
968,309
-963,010
| -50% | -$78.8M | 0.61% | 52 |
|
|
2013
Q3 | $148M | Sell |
1,931,319
-579,440
| -23% | -$45.2M | 1.12% | 26 |
|
|
2013
Q2 | $182M | Buy |
+2,510,759
| New | +$169M | 1.37% | 14 |
|
Other funds holding CI
Cramer Rosenthal McGlynn's CI Position: Q2 2024 in Review
Cramer Rosenthal McGlynn sold out of Cigna (CI) in Q2 2024, closing a stake of 1,000 shares — an estimated $363K sold.
Cramer Rosenthal McGlynn first reported a position in CI in Q2 2013 and held it in 41 quarters. The position peaked at $182M in Q2 2013. 1,666 funds tracked by Wall St. Rank hold CI as of Q2 2024.
- Cramer Rosenthal McGlynn reported no remaining Cigna position as of Q2 2024 after selling out during the quarter.
- Cramer Rosenthal McGlynn sold 1,000 Cigna shares in Q2 2024, an estimated $363K.
- Cramer Rosenthal McGlynn first reported a position in Cigna in Q2 2013 and held it in 41 quarters.
- Cramer Rosenthal McGlynn's Cigna position peaked at $182M in Q2 2013.
- 1,666 funds tracked by Wall St. Rank held Cigna as of Q2 2024.
Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2024, filed 13 Aug 2024.